Purchase Order 75N92025P00401
Award Date
9/29/25
Potential Completion Date
9/28/26
Potential Value
$26K
Funding Federal Agency
National Human Genome Research Institute
Contracting Federal Agency
National Heart Lung and Blood Institute
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $770,306.04, was awarded to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract does not have a set-aside designation. Under this contract, Illumina will provide a range of goods and services to support genomic sequencing...
This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $195,464.40 contract provides for Illumina Sequencers Service Agreement, which includes the procurement of advanced sequencing instruments like NextSeq, NovaSeq, MiSeq, and iSeq systems, along with associated reagents,...
This is a federal contract award to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $149,627.88, was awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract is a delivery order and is a firm fixed-price arrangement, with no set-aside designation. Illumina has previously provided a range of sequencing systems, reagents,...
This is a firm fixed-price delivery order awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical instruments. The contract, valued at $149,982.23, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance services,...
This firm fixed-price delivery order was awarded by the National Human Genome Research Institute (NHGRI), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $93,534.55 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance services, and...
This is a $77,550 firm fixed-price delivery order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract does not have a set-aside designation. The contract provides Illumina's advanced DNA and RNA sequencing instruments, reagents, consumables, maintenance services, and bioinformatics...
This firm fixed-price delivery order was awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for $5,906.00. The contract does not have a set-aside designation. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. Under this order, Illumina will provide various NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, consumables, sample prep kits,...
This is a $127,989.57 firm fixed-price delivery order awarded by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health, to Illumina, Inc., a biotechnology company specializing in genetic sequencing technologies. The contract has a period of performance ending on July 30, 2026. Illumina, a for-profit manufacturer, has been awarded multiple federal contracts and blanket purchase agreements to provide a range of genomic sequencing platforms,...
This is a firm fixed price delivery order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The total ceiling value of the contract is $86,989.68. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, is providing a range of goods and services to support genomic sequencing and analysis for research and diagnostics purposes. This includes various NextSeq, NovaSeq, MiSeq, and...
This is a firm fixed-price delivery order contract awarded by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health, to Illumina, Inc., a manufacturer of sequencing and genomic analysis products. The contract, valued at $100,213.37, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance...